Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.
Condition: SARS CoV 2 Infection Interventions: Drug: Raloxifene; Other: Placebo Sponsor: Dompé Farmaceutici S.p.A Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials